STOCK TITAN

Alr Technologies SEC Filings

ALRTF OTC

Welcome to our dedicated page for Alr Technologies SEC filings (Ticker: ALRTF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

ALR Technologies SG LTD, as a Singapore-based entity, may not file regular SEC reports with the United States Securities and Exchange Commission. Foreign companies trading on U.S. over-the-counter markets are not always required to submit the standard 10-K annual reports, 10-Q quarterly filings, or Form 4 insider transaction documents that domestic issuers provide.

Some foreign issuers voluntarily file Form 6-K reports to disclose material information to U.S. investors, though this varies by company and listing status. For companies without comprehensive SEC filing histories, investors typically rely on press releases, corporate disclosures in home jurisdictions, and financial statements prepared under international accounting standards.

When evaluating companies with limited SEC filing coverage, investors should seek alternative sources of financial information, including annual reports prepared for shareholders in the company's home country, stock exchange announcements required by local regulations, and audited financial statements that may be available through the company's investor relations channels.

Rhea-AI Summary

ALR Technologies SG Ltd. reports that on December 31, 2026 it modified certain share purchase warrants held by two senior insiders. The company extended the expiry date of 4,910,001,500 warrants held by CEO and Chairman Sidney Chan and VP and director Christine Kan from December 31, 2025 to December 31, 2026. Each warrant is exercisable into one ordinary share at an exercise price of $0.002 per share. This change keeps a large block of low-priced warrants in place for an additional year, preserving potential equity participation for these executives.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

ALR Technologies SG Ltd. reports a deepening loss and severe liquidity strain for the six months ended June 30, 2025. Net loss widened to about $10,770,000 from $6,028,000, mainly because interest expense soared to $9,367,270, including $8,187,123 of non-cash share-based compensation from modifying warrants held by the CEO and VP. Core operating expenses actually fell 46% to roughly $1,139,000 as product development, professional, and administrative costs decreased.

The balance sheet is highly stressed. Current liabilities were $38,368,906 versus total assets of only $31,002, leaving a working capital deficit of about $38,338,000 and shareholders’ deficit of $38,337,904. The company had cash of just $1,738 and relies heavily on related-party funding, including $21,164,886 of lines of credit and a $3,822,081 loan. Management discloses substantial doubt about its ability to continue as a going concern, with $11,222,000 of promissory notes and related interest in default and prior default judgments outstanding.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

ALR Technologies SG Ltd. filed a report as a foreign private issuer to share a recent company announcement. The filing states that on December 8, 2025, the company issued a press release, which is attached to the report as Exhibit 99.1.

The press release announced the relaunch of the company’s GluCurve Pet CGM, a continuous glucose monitoring product for pets. This report mainly serves to make that product update publicly available to investors through the SEC’s disclosure system.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

What is the current stock price of Alr Technologies (ALRTF)?

The current stock price of Alr Technologies (ALRTF) is $0.017 as of January 12, 2026.

What is the market cap of Alr Technologies (ALRTF)?

The market cap of Alr Technologies (ALRTF) is approximately 7.7M.
Alr Technologies

OTC:ALRTF

ALRTF Rankings

ALRTF Stock Data

7.70M
246.49M
61.21%
Medical Devices
Healthcare
Link
Singapore
Singapore